$NROM
NOBLE ROMANS INC Stock $nrom

$nrom Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000165495424007662 Filed on June 12, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$3.905M	$3.666M	$3.308M
YoY Change	-2.2%	10.83%	-4.54%
Cost Of Revenue	$2.674M	$2.547M	$1.168M
YoY Change	0.3%	118.11%	-55.98%
Gross Profit	$1.230M	$1.119M	$2.140M
YoY Change	-7.22%	-47.7%	163.42%
Gross Profit Margin	31.51%	30.53%	64.7%
Selling, General & Admin	$570.1K	$577.3K	$518.8K
YoY Change	8.33%	11.27%	-4.01%
% of Gross Profit	46.34%	51.58%	24.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$216.6K	$212.1K	$201.3K
YoY Change	-3.44%	5.37%	-14.29%
% of Gross Profit	17.6%	18.95%	9.4%
Operating Expenses	$2.674M	$2.547M	$1.168M
YoY Change	0.3%	118.11%	78.74%
Operating Profit	$557.9K	$432.2K	$1.526M
YoY Change	-20.79%	-71.67%	858.73%
Interest Expense	$435.2K	$394.2K	$383.3K
YoY Change	14.89%	2.84%	12.11%
% of Operating Profit	78.0%	91.2%	25.12%
Other Income/Expense, Net	-$65.89K	-$124.5K
YoY Change
Pretax Income	$56.86K	-$86.48K	$1.142M
YoY Change	-82.54%	-107.57%	-725.19%
Income Tax	$0.00	$0.00	$274.2K
% Of Pretax Income	0.0%		24.0%
Net Earnings	$56.86K	-$86.48K	$868.3K
YoY Change	-82.54%	-109.96%	-735.18%
Net Earnings / Revenue	1.46%	-2.36%	26.25%
Basic Earnings Per Share	$0.00	$0.00	$0.04
Diluted Earnings Per Share	$0.00	$0.00	$0.04
COMMON SHARES
Basic Shares Outstanding	22.22M shares	22.22M shares	22.22M shares
Diluted Shares Outstanding	23.71M shares	22.22M shares	23.63M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$801.1K	$1.165M	$463.3K
YoY Change	16.78%	151.49%	-42.66%
Cash & Equivalents	$801.1K	$1.165M	$463.3K
Short-Term Investments
Other Short-Term Assets	$200.2K	$280.7K	$401.4K
YoY Change	-51.26%	-30.06%	-9.11%
Inventory	$987.8K	$999.6K	$1.007M
Prepaid Expenses	$200.2K	$280.7K	$401.4K
Receivables	$696.7K	$720.3K	$377.6K
Other Receivables	$507.7K	$507.7K	$1.460M
Total Short-Term Assets	$3.193M	$3.673M	$4.183M
YoY Change	-26.9%	-12.18%	33.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.171M	$4.242M	$4.631M
YoY Change	-8.35%	-8.39%	-59.12%
Goodwill	$278.5K	$278.5K	$278.5K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.801M	$4.782M	$4.044M
YoY Change	18.74%	18.26%	934.72%
Total Long-Term Assets	$14.16M	$14.33M	$14.82M
YoY Change	-2.84%	-3.25%	-8.14%
TOTAL ASSETS
Total Short-Term Assets	$3.193M	$3.673M	$4.183M
Total Long-Term Assets	$14.16M	$14.33M	$14.82M
Total Assets	$17.35M	$18.01M	$19.00M
YoY Change	-8.39%	-5.22%	-1.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$615.5K	$1.089M	$598.8K
YoY Change	7.59%	81.89%	-1.45%
Accrued Expenses	$834.7K	$817.4K	$799.2K
YoY Change	4.45%	2.28%	19.49%
Deferred Revenue
YoY Change
Short-Term Debt	$575.0K	$575.0K	$0.00
YoY Change
Long-Term Debt Due	$6.893M	$7.029M	$1.000M
YoY Change	589.28%	602.85%
Total Short-Term Liabilities	$9.649M	$10.18M	$2.398M
YoY Change	306.92%	324.33%	87.87%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$7.956M
YoY Change	-100.0%	-100.0%	-7.6%
Other Long-Term Liabilities	$5.533M	$5.724M	$5.903M
YoY Change	-3.4%	-3.04%	-10.72%
Total Long-Term Liabilities	$5.533M	$5.724M	$13.86M
YoY Change	-59.0%	-58.7%	-8.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.649M	$10.18M	$2.398M
Total Long-Term Liabilities	$5.533M	$5.724M	$13.86M
Total Liabilities	$15.18M	$15.90M	$16.26M
YoY Change	-4.3%	-2.2%	-1.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.68M	-$22.74M	-$22.08M
YoY Change	4.23%	2.95%
Common Stock	$24.85M	$24.84M	$24.83M
YoY Change	0.05%	0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.167M	$2.107M	$2.741M
YoY Change
Total Liabilities & Shareholders Equity	$17.35M	$18.01M	$19.00M
YoY Change	-8.39%	-5.22%	-1.38%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$56.86K	-$86.48K	$868.3K
YoY Change	-82.54%	-109.96%	-735.18%
Depreciation, Depletion And Amortization	$216.6K	$212.1K	$201.3K
YoY Change	-3.44%	5.37%	-14.29%
Cash From Operating Activities	-$88.72K	$561.6K	-$192.2K
YoY Change	-116.47%	-392.13%	-1870.79%
INVESTING ACTIVITIES
Capital Expenditures	$25.30K	$18.83K	$13.34K
YoY Change	57.2%	41.21%	-97.14%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$25.30K	-$18.83K	-$13.34K
YoY Change	57.2%	41.21%	-97.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-250.0K	-$250.0K	-$116.7K
YoY Change	-16.67%	114.29%
NET CHANGE
Cash From Operating Activities	-88.72K	$561.6K	-$192.2K
Cash From Investing Activities	-25.30K	-$18.83K	-$13.34K
Cash From Financing Activities	-250.0K	-$250.0K	-$116.7K
Net Change In Cash	-364.0K	$292.7K	-$322.2K
YoY Change	-263.46%	-190.85%	-29.26%
FREE CASH FLOW
Cash From Operating Activities	-$88.72K	$561.6K	-$192.2K
Capital Expenditures	$25.30K	$18.83K	$13.34K
Free Cash Flow	-$114.0K	$542.7K	-$205.6K
YoY Change	-121.81%	-364.01%	-54.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	1169446	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	965819	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	318195	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3833521	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4386430	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3130430	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	1403299	usd
CY2023Q4	us-gaap	Goodwill Goodwill	278466	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4930014	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1284210	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	799165	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22215512	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1165078	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7535692	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4242433	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3374841	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3374841	usd
CY2024Q1	us-gaap	Deferred Costs DeferredCosts	1407286	usd
CY2024Q1	us-gaap	Goodwill Goodwill	278466	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4741552	usd
CY2024Q1	us-gaap	Assets Assets	18006484	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1089045	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	817386	usd
CY2024Q1	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	1425290	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7516860	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3196993	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4319867	usd
CY2023Q4	us-gaap	Assets Assets	18479825	usd
CY2023Q1	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	121830	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1167705	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	2546871	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	96266	usd
CY2023Q4	nrom	Employee Retention Tax Credit Receivable EmployeeRetentionTaxCreditReceivable	507726	usd
CY2024Q1	nrom	Employee Retention Tax Credit Receivable EmployeeRetentionTaxCreditReceivable	507726	usd
CY2024Q1	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	720303	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	999555	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	280710	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	3673372	usd
CY2024Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4399613	usd
CY2024Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3136079	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4378927	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4167011	usd
CY2023Q4	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	1577299	usd
CY2024Q1	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	1556976	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12664917	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5723987	usd
CY2024Q1	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	225760	usd
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000709005
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18479825	usd
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Entity File Number EntityFileNumber	0-11104
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	NOBLE ROMAN’S, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IN
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-1281154
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6612 E
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	75th Street
CY2024Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 450
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Indianapolis
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46250
CY2024Q1	dei	City Area Code CityAreaCode	317
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	634-3377
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22215512	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	872335	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3293259	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	339817	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	288534	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1000000	usd
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	7028519	usd
CY2023Q4	us-gaap	Subordinated Debt SubordinatedDebt	0	usd
CY2024Q1	us-gaap	Subordinated Debt SubordinatedDebt	575000	usd
CY2023Q4	nrom	Warrant Liability Current WarrantLiabilityCurrent	540650	usd
CY2024Q1	nrom	Warrant Liability Current WarrantLiabilityCurrent	665150	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3624025	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10175100	usd
CY2023Q4	nrom	Loan Payable Non Current LoanPayableNonCurrent	6133691	usd
CY2024Q1	nrom	Loan Payable Non Current LoanPayableNonCurrent	0	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	575000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	16288942	usd
CY2024Q1	us-gaap	Liabilities Liabilities	15899087	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	24840126	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	24843117	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22649243	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22735720	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2190883	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	2107397	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18006484	usd
CY2024Q1	nrom	Increase Decreasein Employee Retention Tax Credit IncreaseDecreaseinEmployeeRetentionTaxCredit	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-27134	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	449143	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8821	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-33736	usd
CY2023Q1	nrom	Revenue Restaurant Revenue Company Owned Craft Pizza Pub RevenueRestaurantRevenueCompanyOwnedCraftPizzaPub	2090342	usd
CY2024Q1	nrom	Revenue Restaurant Revenue Company Owned Craft Pizza Pub RevenueRestaurantRevenueCompanyOwnedCraftPizzaPub	1995524	usd
CY2023Q1	nrom	Revenue From Company Owned Restaurants Nontraditional RevenueFromCompanyOwnedRestaurantsNontraditional	223381	usd
CY2024Q1	nrom	Revenue From Company Owned Restaurants Nontraditional RevenueFromCompanyOwnedRestaurantsNontraditional	238147	usd
CY2023Q1	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	987342	usd
CY2023Q1	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	6738	usd
CY2024Q1	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	7144	usd
CY2023Q1	us-gaap	Revenues Revenues	3307803	usd
CY2024Q1	us-gaap	Revenues Revenues	3666105	usd
CY2023Q1	nrom	Restaurant Expenses Company Owned Craft Pizza Pub RestaurantExpensesCompanyOwnedCraftPizzaPub	1914821	usd
CY2024Q1	nrom	Restaurant Expenses Company Owned Craft Pizza Pub RestaurantExpensesCompanyOwnedCraftPizzaPub	1831444	usd
CY2023Q1	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	-868946	usd
CY2024Q1	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	489667	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	95517	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	518832	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	577286	usd
CY2024Q1	nrom	Defense Against Activist Shareholder DefenseAgainstActivistShareholder	13479	shares
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1782054	usd
CY2024Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3233902	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1525749	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	432203	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	383289	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	394180	usd
CY2023Q1	nrom	Gain Loss On Change In Fair Value Of Warrants GainLossOnChangeInFairValueOfWarrants	0	usd
CY2024Q1	nrom	Gain Loss On Change In Fair Value Of Warrants GainLossOnChangeInFairValueOfWarrants	124500	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1142460	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-86477	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	274190	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	868270	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-86477	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23628012	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2190883	usd
CY2024Q1	nrom	Amortization Of Value Of Stock Options AmortizationOfValueOfStockOptions	2991	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-86477	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	2107397	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	710209	usd
CY2023Q1	nrom	Amortization Of Value Of Stock Options AmortizationOfValueOfStockOptions	6395	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	868270	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1584874	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	868270	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-86477	usd
CY2023Q1	nrom	Gain Loss On Change In Fair Value Of Warrants GainLossOnChangeInFairValueOfWarrants	0	usd
CY2024Q1	nrom	Gain Loss On Change In Fair Value Of Warrants GainLossOnChangeInFairValueOfWarrants	124500	usd
CY2023Q1	nrom	Stock Options Amortization Value StockOptionsAmortizationValue	6395	usd
CY2024Q1	nrom	Stock Options Amortization Value StockOptionsAmortizationValue	2991	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	194857	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	212051	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	25253	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	15818	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	274190	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023Q1	nrom	Increase Decreasein Employee Retention Tax Credit IncreaseDecreaseinEmployeeRetentionTaxCredit	-1460444	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	23453	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	37485	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-27422	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	51283	usd
CY2023Q1	nrom	Increase Decrease In Deferred Contract Income IncreaseDecreaseInDeferredContractIncome	0	usd
CY2024Q1	nrom	Increase Decrease In Deferred Contract Income IncreaseDecreaseInDeferredContractIncome	-20306	usd
CY2023Q1	nrom	Increase Decrease In Deferred Contract Cost IncreaseDecreaseInDeferredContractCost	0	usd
CY2024Q1	nrom	Increase Decrease In Deferred Contract Cost IncreaseDecreaseInDeferredContractCost	3987	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-60834	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-195164	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-192237	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	561575	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13336	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18832	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13336	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18832	usd
CY2023Q1	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	116667	usd
CY2024Q1	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	250000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-116667	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-322240	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	292743	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	785523	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	872335	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463283	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1165078	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	271160	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	278395	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1718000	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1718000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	258000	usd
CY2024Q1	nrom	Net Benefit Or Refund NetBenefitOrRefund	1460000	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	83000	usd
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	182991	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	191267	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	35692	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	29072	usd
CY2024Q1	nrom	Equipment Inventory EquipmentInventory	780872	usd
CY2023Q1	nrom	Equipment Inventory EquipmentInventory	786350	usd
CY2024Q1	us-gaap	Other Inventory OtherInventory	999555	usd
CY2023Q1	us-gaap	Other Inventory OtherInventory	1006689	usd
CY2024Q1	nrom	Royalty And Feees Description RoyaltyAndFeeesDescription	deferring initial fees of $52,500 and amortizing $43,779 of previously deferred fees and receiving $20,000 in transfer fees
CY2024Q1	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	1456000	usd
CY2023Q1	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	987000	usd
CY2024Q1	us-gaap	Deferred Income DeferredIncome	1557000	usd
CY2024Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	1407000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23628012	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
nrom-20240331_pre.xml	Edgar Link	unprocessable
0001654954-24-007662-index-headers.html	Edgar Link	pending
0001654954-24-007662-index.html	Edgar Link	pending
0001654954-24-007662.txt	Edgar Link	pending
0001654954-24-007662-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nrom-20240331.xsd	Edgar Link	pending
nrom_10q.htm	Edgar Link	pending
nrom_ex311.htm	Edgar Link	pending
nrom_ex312.htm	Edgar Link	pending
nrom_ex321.htm	Edgar Link	pending
nrom_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nrom-20240331_cal.xml	Edgar Link	unprocessable
nrom-20240331_def.xml	Edgar Link	unprocessable
nrom-20240331_lab.xml	Edgar Link	unprocessable
nrom_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NROM
NOBLE ROMANS INC Stock $nrom

2024 Q2 Form 10-Q Financial Statement

#000165495424007662 Filed on June 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM NOBLE ROMANS INC Stock $nrom

2024 Q2 Form 10-Q Financial Statement

#000165495424007662 Filed on June 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM
NOBLE ROMANS INC Stock $nrom